Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced Hypertonic Solutions for Cerebral Edema
NCT03330704Phase 1Withdrawn
- Sponsor
- Stanford University
- Start
- Nov 2017
- Primary completion
- Jan 2020
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sodium chloride and sodium bicarbonate ringer's solution in cerebral edema, sponsored by Stanford University. Primary endpoint: Total volume of intravenous hypertonic fluid administered at 1 week. Planned start Nov 2017; status: withdrawn.
02
Drugs
sodium chloridesodium bicarbonate ringer's solution
03
Conditions
cerebral edema
Beyond the preview
Go deeper on NCT03330704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03330704.